LifeStance Health Group (LFST) Expected to Announce Quarterly Earnings on Thursday

LifeStance Health Group (NASDAQ:LFST) will likely be issuing its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $313.96 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

LifeStance Health Group Stock Performance

NASDAQ LFST opened at $7.59 on Tuesday. LifeStance Health Group has a 52-week low of $4.64 and a 52-week high of $9.20. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The company has a market capitalization of $2.90 billion, a P/E ratio of -29.19 and a beta of 1.28. The company has a fifty day moving average of $7.77 and a 200-day moving average of $7.19.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Barclays boosted their price target on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. The Goldman Sachs Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research note on Monday, December 16th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, LifeStance Health Group currently has an average rating of “Hold” and a consensus target price of $8.70.

Insiders Place Their Bets

In other news, Director Robert Bessler sold 75,000 shares of the company’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total transaction of $565,500.00. Following the completion of the transaction, the director now directly owns 1,424,447 shares of the company’s stock, valued at approximately $10,740,330.38. This represents a 5.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 6.60% of the stock is currently owned by insiders.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.